Fine Foods & Pharmaceuticals N.T.M. S.p.A. - Laporan Laba Rugi (TTM)

Fine Foods & Pharmaceuticals N.T.M. S.p.A.
IT ˙ BIT ˙ IT0005215329
€ 8.66 ↑0.04 (0.46%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Fine Foods & Pharmaceuticals N.T.M. S.p.A. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 162 177 190 200 198 195 194 196 203 207 222 234 240 252 252 247 244 244 242 250
Change (%) 9.06 7.59 5.47 -1.01 -1.76 -0.30 0.77 3.49 2.10 7.16 5.45 2.56 5.13 0.00 -1.84 -1.55 0.32 -1.05 3.50
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 113 123 132 139 138 139 141 143 150 153 162 173 176 183 182 174 168 164 159 163
Change (%) 8.19 7.33 5.32 -0.38 0.53 1.30 1.35 4.89 2.18 5.90 6.54 2.12 4.13 -0.78 -4.56 -3.56 -1.98 -3.14 2.62
% of Revenue 70.08 69.52 69.35 69.25 69.69 71.32 72.46 72.87 73.86 73.92 73.06 73.82 73.50 72.80 72.23 70.22 68.79 67.21 65.79 65.23
Gross Operating Profit 48 54 58 62 60 56 54 53 53 54 60 61 64 69 70 74 76 80 83 87
Change (%) 11.08 8.18 5.83 -2.41 -7.04 -4.26 -0.76 -0.28 1.87 10.72 2.48 3.81 7.91 2.10 5.25 3.18 5.41 3.24 5.20
% of Revenue 29.92 30.48 30.65 30.75 30.31 28.68 27.54 27.13 26.14 26.08 26.94 26.18 26.50 27.20 27.77 29.78 31.21 32.79 34.21 34.77
SG&A 28 31 33 34 35 35 36 38 39 39 40 42 43 45 46 46 47 48 50 52
Change (%) 11.55 5.50 4.17 1.66 2.26 1.30 5.08 2.36 0.22 4.58 3.35 2.41 5.45 1.05 1.07 1.82 2.89 3.50 3.44
% of Revenue 17.15 17.55 17.21 16.99 17.45 18.16 18.46 19.25 19.04 18.68 18.24 17.87 17.84 17.90 18.09 18.62 19.26 19.75 20.66 20.65
R&D
Change (%)
% of Revenue
OpEx 153 166 177 186 186 189 192 196 204 207 218 230 239 246 245 238 228 230 226 232
Change (%) 8.26 6.66 5.05 0.16 1.43 1.42 2.22 4.19 1.67 5.31 5.44 3.82 2.91 -0.35 -3.02 -3.91 0.64 -1.56 2.37
% of Revenue 94.64 93.95 93.14 92.77 93.86 96.92 98.58 100.00 100.67 100.25 98.52 98.51 99.72 97.61 97.26 96.09 93.79 94.09 93.61 92.58
Operating Income 9 11 13 14 12 6 3 0 -1 -1 3 3 1 6 7 10 15 14 15 19
Change (%) 23.13 22.06 11.22 -16.02 -50.65 -54.13 -99.76 -21,009.47 -62.73 -745.45 6.01 -80.60 793.23 14.40 40.14 56.59 -4.50 6.98 20.05
% of Revenue 5.36 6.05 6.86 7.23 6.14 3.08 1.42 0.00 -0.67 -0.25 1.48 1.49 0.28 2.39 2.74 3.91 6.21 5.91 6.39 7.42
Interest Expense -0 -0 -1 -1 -1 -1 -1 -1 -2 -2 -3 -4 -4 -5 -5 -4 -4 -3 -3 -3
Change (%) 11.33 9.04 9.31 35.57 -10.89 25.78 -1.04 87.48 27.00 35.86 35.48 9.37 17.40 0.60 -8.65 -8.19 -18.73 -11.58 -6.51
% of Revenue -0.26 -0.27 -0.27 -0.28 -0.39 -0.35 -0.44 -0.44 -0.79 -0.98 -1.25 -1.60 -1.71 -1.91 -1.92 -1.79 -1.67 -1.35 -1.21 -1.09
Net Income 8 13 13 2 -1 -1 -6 -1 -10 -10 -4 -5 1 -4 -4 3 5 8 9 12
Change (%) 66.80 -4.40 -83.17 -125.11 164.18 299.07 -82.51 947.33 -8.88 -56.71 24.70 -112.24 -661.05 2.51 -172.30 85.86 68.10 14.95 32.71
% of Revenue 4.95 7.57 6.73 1.07 -0.27 -0.73 -2.93 -0.51 -5.15 -4.59 -1.86 -2.19 0.26 -1.40 -1.43 1.06 1.99 3.34 3.88 4.97

Source: Capital IQ

Other Listings
DE:9S5
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista